On October 12, 2007, the U.S. Food and Drug Administration (FDA) published several announcements in the Federal Register. Two announcements describe new amounts for user fees that must be submitted with applications to the FDA to produce or market medical devices or drugs, and another announcement describes a “public workshop” on the evaluation of cell/scaffold medical products.
